Marshall Wace North America L.P. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,316,000
+2518.3%
511,674
+2758.0%
0.04%
+2100.0%
Q4 2020$394,000
-76.1%
17,903
-80.5%
0.00%
-81.8%
Q3 2020$1,651,000
-22.3%
91,810
-20.6%
0.01%
-31.2%
Q1 2020$2,125,000
-54.4%
115,666
-45.4%
0.02%
-30.4%
Q4 2019$4,665,000
+58212.5%
211,789
+41024.1%
0.02%
Q3 2019$8,000
-98.5%
515
-98.6%
0.00%
-100.0%
Q1 2019$522,000
+884.9%
35,772
+623.1%
0.00%
+100.0%
Q4 2018$53,0004,9470.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders